Related Experiment Video
Updated: Jul 4, 2025

10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.2K
[Migraine and pregnancy : Gender-specific aspects and current knowledge]
Bianca Raffaelli1,2, Kristin S Lange3
1Kopfschmerzzentrum, Klinik für Neurologie, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland. bianca.raffaelli@charite.de.
Der Nervenarzt
|February 6, 2024
Summary
Pregnancy often improves migraine symptoms for many women, though headaches may return postpartum. Careful risk-benefit analysis is essential for selecting safe migraine treatments during pregnancy.
Area of Science:
- Neurology
- Obstetrics
- Women's Health
Context:
- Migraine is a common neurological disorder with significant gender-specific variations.
- Pregnancy presents unique challenges and considerations for migraine management.
- Understanding migraine's impact during pregnancy is crucial for patient care.
Purpose:
- To review how pregnancy affects migraine course.
- To outline treatment options for migraine during pregnancy.
- To identify critical differential diagnoses for headaches in pregnant individuals.
Summary:
- Up to 75% of women experience migraine improvement during pregnancy.
- Postpartum, migraine frequency may increase.
- Treatment decisions require careful risk-benefit assessment, considering potential fetal and maternal risks.
- Secondary causes of headache are more common in pregnancy and can be serious.
Impact:
- Highlights the need for individualized migraine management strategies during pregnancy.
- Emphasizes the importance of considering secondary headaches in pregnant patients.
- Informs clinical practice for optimizing care for women with migraine who are pregnant.
Related Concept Videos
Panic Disorder
114
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
114
Disorders of the Female Reproductive System
363
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
363
Adrenergic Antagonists: ɑ and β-Receptor Blockers
448
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
448
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K

